XRCC1 and XRCC3 variants and risk of glioma and meningioma
Anne Kiuru(Radiation and Nuclear Safety Authority), Anssi Auvinen(Tampere University of Applied Sciences), Maria Feychting(Karolinska Institutet), Anthony J. Swerdlow(Institute of Cancer Research), Beatrice Malmer(Mayo Clinic), Stefan Lönn(Hallands sjukhus Halmstad), Minouk J. Schoemaker(Institute of Cancer Research), Tiina Salminen, Christoffer Johansen(University of Copenhagen), Helle Collatz Christensen(Region Zealand), Hannu Haapasalo(Tampere University Hospital), Päivi Jokinen(Radiation and Nuclear Safety Authority), Carita Lindholm(National Institutes of Health), Taina Ilus(Radiation and Nuclear Safety Authority), Sirpa Heinävaara(University of Helsinki)
Cited by 82
Related Papers
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks
|Radiation Research|2007|678
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries
|BMJ|2005|600
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
|JNCI Journal of the National Cancer Institute|2015|570